Back
Corporate News
Aptus Pharma to convene board meeting August 17, 2026, for valuation report
12-Aug-2026, 06:49
Aptus Pharma Limited will hold a board meeting on August 17, 2026, to consider a valuation report for a preferential issue of 16,10,100 equity shares, determine an issue price based on a valuation report from a registered valuer, and take record of a PCS certificate confirming compliance with ICDR and Companies Act, 2013 provisions. The company will also convene its 16th Annual General Meeting on September 14, 2026, via video conferencing and approve the notice for the meeting. Trading window for designated persons and their immediate relatives will be closed from August 12, 2026, at 6:00 p.m. until 48 hours after the board meeting outcome is disseminated.
Aptus Pharma Limited will hold a board meeting on August 17, 2026, to consider a valuation report for a preferential issue of 16,10,100 equity shares, determine an issue price based on a valuation report from a registered valuer, and take record of a PCS certificate confirming compliance with ICDR and Companies Act, 2013 provisions. The company will also convene its 16th Annual General Meeting on September 14, 2026, via video conferencing and approve the notice for the meeting. Trading window for designated persons and their immediate relatives will be closed from August 12, 2026, at 6:00 p.m. until 48 hours after the board meeting outcome is disseminated.